70 - Reframing the Framework: Fresh approaches and novel ideas to using the Translational Science Benefits Model (TSBM).

Abstract Information: Emergent environments require fresh perspectives and new ideas in order to continue to expand the field. The bidirectional engagement of experienced and novice evaluators allows for new opportunities for growth and innovation. Within the Clinical and Translational Research (CTR) Evaluation field, we are charged with helping to identify barriers and facilitators in Translational Research. New and innovative approaches must be developed in assessing all aspects of translational impacts in a nuanced way. The Translational Science Benefits Model (TSBM) has grown in popularity among CTSA evaluators as a potential methodological approach to assessing study/study team impacts. Developed to help study teams track 30 benefits in four primary domains (clinical, community, economic, and policy), this session wants to explore whether there are other key translational players, such as CTR program administrators, students, or trainees, who can give new insight into process related facilitators and barriers and contribute to identifying administrative areas that can assist in moving translation faster and forward.